Global Intravenous (IV) Iron Drugs Market: 2011 Edition


January 1, 2012
41 Pages - SKU: KOAN6795966
License type:
Countries covered: Global

Iron is one of the most important minerals present in the human body and performs the task of carrying oxygen throughout the body through blood, which is then further utilized by the cells to get energy. Decline in iron can therefore lead to certain major problems. Although oral iron supplements can be used to maintain the iron levels in the body, but oral supplements are chronic treatments and generally have poor absorption, poor compliance, and can have certain side effects. In such cases, IV iron therapy proves out to be the best option. Presently, oral iron dominates the global iron market, holding more than half of the market. But with the increasing use of IV iron, its share is expected to increase and surpass that of oral iron.

The global market for IV iron is increasing in the past years. Nephrology remains the largest segment of use for the IV iron therapies, and accounts for more than three-fourths of the overall market. With the ongoing research and development to increase the use of IV iron therapies in other therapeutic areas, including gynaecology, gastroenterology, oncology, chronic heart failures and surgeries, the IV iron market would certainly benefit. There are certain types of IV iron products being marketed and used worldwide, some of which include low molecular weight iron dextran, iron sucrose, ferric gluconate, and ferric carboxylmaltose. The US is the largest IV iron market worldwide, followed by European Union.

More than 90% of the dialysis patients receive IV iron therapies, and there is an expected increase in the number of dialysis patients, on the back of ageing population, growing prevalence of hypertension, obesity and diabetes. Therefore, the global IV iron market is likely to increase in the coming years.

Vifor Pharma, a part of Galenica Group is the leading company in IV Iron market worldwide, with its two products, Venofre and Ferinject. Some of the other major companies in this sector include Watson Pharmaceuticals (INFeD), and AMAG Pharmaceuticals (Feraheme).

The present report analyzes the global IV iron market, with focus on some of the major regional markets, including the US, Europe and Switzerland. Major drivers being discussed in this report are rapidly ageing population, increase use of IV iron in gynecology, and improving results of IV iron in other therapeutic areas including the chronic heart diseases and pre dialysis. Also, the report presents some of the major issues concerning the industry. The leading companies are being profiled, along with their key financials and strategies for growth.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.



More Needles, Syringes, IV Access reports by Koncept Analytics

Global Intravenous Immunoglobulin (IVIG) Market: An Analysis by Koncept Analytics
Intravenous Immunoglobulin (IVIG) has been the driving force of the growth of plasma products industry. The demand for IVIG has been growing on account of ...
See all reports like this >>

More Global Needles, Syringes, IV Access reports

Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017 by MarketsandMarkets
The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a ...
World Infection Prevention by Freedonia Group Inc
World demand to rise 5.2% annually through 2017 World demand for infection prevention products is forecast to increase 5.2 percent annually to $109 billion in ...
The World Market for Implantable and Needle-Free Drug Delivery Systems by Kalorama Information
This report, The World Market for Implantable and Needle-Free Drug Delivery details the types of drug delivery systems and technologies that are being used in ...
Global Prefilled Syringes Market: Trends & Opportunities (2012-2017) by Daedal Research
Pre-Filled Syringes market is growing at a very rapid pace owing to its usability, convenience, accuracy of dose and shortest possible time for injecting medicine. ...
See all reports like this >>